Stryker | SYK - Sales Revenues

Stock Price
329.65
Daily Change
0.30 0.09%
Monthly
0.35%
Yearly
-8.70%
Q2 Forecast
335.77

Stryker reported $7.2B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
CONMED USD 373.2M 35.3M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Olympus JPY 261.05B 13.21B Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025